On Jan 02, Thomas Thomas A, Director sold 30,000 shares of Switch Inc. (NYSE: SWCH), with the average selling price of the stock being $14.69 per share. The total amount realized from this sold $440,550. A document was filed with the Securities and Exchange Commission to notify the public about the sold of the shares.
In addition to that, Director – Thomas Thomas A sold an extra 30,000 shares of this stock in a transaction that took place a day before, on Dec 02, with a share sold at an average of $15.40 and a total of $461,850 was realized from this transaction. After the transaction, the Director – Thomas Thomas A was left with 954,135 shares of the company’s stock, which is currently worth around $14693679.0.
The recent price movement of SWCH means that it is now down by -5.13% from its 52-week high and 114.69% up against its 52-week low prices. Over the past one week, the price volatility of SWCH stands at 2.86% while the volatility over the past one month is 2.41%.
The company on 11/07/2019 published its latest quarterly earnings, with the report showing that the company recorded 0.05 earnings per share (EPS) during that period. This report was above the expectations of analysts of 0.03 by 0.02. The revenue by the firm was 119.28M for the quarter.
The shares of Switch Inc. (SWCH) gained by 3.14%, leading to a gain of $0.49 per share, and saw SWCH end the trading session at $16.08 on Wednesday 01/15/20. SWCH started the trading session at $15.64, before reaching a daily high of $16.25. It wasn’t able to sustain that growth though and soon jumped to hit a daily low of $15.63.
The trading volume on Wednesday stood at 1505412, which was below the stock’s 3-month average volume of 872.91K shares, out of a total 58.12M shares. As the price of the stock climbed, the market valuation of the company gained to 3.85 billion.
The shares of Iron Mountain Incorporated (NYSE: IRM) went up by 0.62% by the end of the recent trading session. This movement saw its price surge to close at $30.79, which was higher than the previous closing price of $30.60. Over the past one week, the price of IRM has slipped by -0.52%, while it has recorded a loss of -2.53% over the past one month. Its three-month performance saw IRM lose -6.10% while its six-month performance saw it surge by 2.12%. The situation is different though over the past one year, as the stock price went down by -11.62%, while its year-to-date (YTD) price performance slipped by -3.39%. The stock price has gone up by +1.95% compared to its 90-day low, while it is down -10.60% compared to its 90-day high price.
Let’s take a look at its short, medium and long-term indicators. Composite Indicators shows that Trendspotter rated the stock as a Sell. In the short-term, the stock has a 20-day average volume of 2,836,870 shares, with the short-term indicators averagely rating the stock as a 100% Sell. A look at its medium-term indicators reveals that it has a 50-Day average volume of 2,537,712 shares and the indicators have an average rating of Hold. The last indicators, the long-term see IRM stock with a 100-Day average volume of 2,383,862 shares, giving it an average rating of 50% Sell. A look at the general picture of all short, medium and long-term indicators leaves IRM with an average rating of 56% Sell.
Several brokerage firms sent out their reports IRM stock not long ago. In its report sent out on August 02, 2019, Robert W. Baird lowered its ratings on IRM from a Underperform to a Neutral. In an earlier report on July 11, 2019, BofA/Merrill Downgrade the stock from a Neutral to a Underperform. Wells Fargo meanwhile in its report on July 10, 2019 Initiated its rating of the stock to “Outperform”.
In related news to the company’s stock, around 86.20% shares are being held by institutional investors. In a recent SEC filing, the company revealed that 564 institutions currently hold the IRM stock. In the last quarter, a 240,415,173 IRM shares were in the possession of institutions. On the other hand, the company recorded 59 new institutions who bought it their stock, while 55 institutions sold their entire IRM reserve. Of the current institutions investing in the stock, 270 increased their investment while 209 decreased their investment in the stock.